← European Medicine Shortage Tracker · all medicines

Idroclorotiazide + lisinopril shortage — availability across Europe

Idroclorotiazide + lisinopril currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: IDROCLOROTIAZIDE + LISINOPRIL · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Idroclorotiazide + lisinopril, covering 1 affected product presentation. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
LISINOPRIL E IDROCLOROTIAZIDE DOC GENERICI
2026-08-31Problemi regolatori
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

Full report history (1 register entry)

Every individual register entry for Idroclorotiazide + lisinopril in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITLISINOPRIL E IDROCLOROTIAZIDE DOC GENERICIShortage2026-08-31Problemi regolatori

Frequently asked

Is Idroclorotiazide + lisinopril currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Idroclorotiazide + lisinopril?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Idroclorotiazide + lisinopril availability data come from?

Directly from the official medicines-agency register that lists Idroclorotiazide + lisinopril: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Idroclorotiazide + lisinopril — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/idroclorotiazide-lisinopril/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Idroclorotiazide + lisinopril availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/idroclorotiazide-lisinopril/">Idroclorotiazide + lisinopril shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Idroclorotiazide + lisinopril: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.